Cue Biopharma, Inc. - Common Stock, par value $0.001 per share (CUE)

CUSIP: 22978P106

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
-514,358
Put/Call ratio
424%
SEC-reported price per share
$12.20
Indexed holders
88
Value change
-$6,452,286
Number of buys
34
Open additional details 1 more signal available
Number of sells
46
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
7,559,966

Security key

22978P106

Report period

Q1 2021

Indexed institutions

88

Top holders

10

Ownership snapshot

Top reported holders of CUE - Cue Biopharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $31,360,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Nantahala Capital Management, LLC has the largest disclosed position value at $31.36M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nantahala Capital Management, LLC's linked filing trail.
Disclosed position value Top 5
Nantahala Capital Management, LLC $31.36M
BlackRock Finance, Inc. $27.06M
Corriente Advisors, LLC $23.96M
Slate Path Capital LP $18.56M
VANGUARD GROUP INC $18.07M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$31,360,000
2,506,772 shares
— 31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$27,059,000
2,162,978 shares
— 31 Dec 2020
Corriente Advisors, LLC
13F
Company
13F
—
denominator unverified
$23,959,000
1,915,219 shares
— 31 Dec 2020
Slate Path Capital LP
13F
Company
13F
—
denominator unverified
$18,560,000
1,483,619 shares
— 31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$18,070,000
1,444,537 shares
— 31 Dec 2020
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$17,409,000
1,391,578 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
88
Shares
18,817,560
Indexed holders
88
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 indexed holders
94
Q1 2021 indexed holders
88
Indexed holder difference
-6
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .